Liver disease induced coagulopathy: Difference between revisions
(Text replacement - "w/o" to "with out") |
Neil.m.young (talk | contribs) (Text replacement - " w/ " to " with ") |
||
Line 23: | Line 23: | ||
*[[Vitamin K]] PO or IV | *[[Vitamin K]] PO or IV | ||
*[[Desmopressin]] | *[[Desmopressin]] | ||
**Effective | **Effective with minimal side effects | ||
**0.3 mg/kg IV (preferred) or SC (max 20mg) | **0.3 mg/kg IV (preferred) or SC (max 20mg) | ||
**Onset of action ~1hr, duration of action ~4-24hr | **Onset of action ~1hr, duration of action ~4-24hr | ||
*[[Cryoprecipitate]] | *[[Cryoprecipitate]] | ||
**May be used to replace fibrinogen in patients | **May be used to replace fibrinogen in patients with fibrinogen levels <100 | ||
**1 bag per 10kg of body weight | **1 bag per 10kg of body weight | ||
*[[Platlets]] | *[[Platlets]] |
Revision as of 17:44, 12 July 2016
Background
Clinical Features
Differential Diagnosis
Coagulopathy
Platelet Related
- Too few
- Nonfunctional
Factor Related
- Acquired (Drug Related)
- Warfarin (Coumadin)
- Unfractionated heparin
- Low molecular weight heparin (i.e. enoxaparin (Lovenox), dalteparin)
- Factor Xa Inhibitors (e.g. rivaroxaban, apixaban, fondaparinux, edoxaban)
- Direct thrombin inhibitors (e.g. dabigatran, argatroban, bivalirudin)
- Illness induced
- Genetic
Diagnosis
- PT prolongation
- Decreased synthesis of vitamin K-dependent factors (II, VII, IX, X)
- Thrombocytopenia
- Portal hypertension -> congestive hypersplenism -> splenic sequestration
- Fibrinolysis increased
- Due to decreased synthesis of alpha2 plasmin inhibitor
- Low fibrinogen level, mild elevation of FDP and D-dimer
Management
Lab abnormalities only (with out significant bleeding)
- Observation
Significant bleeding
- Vitamin K PO or IV
- Desmopressin
- Effective with minimal side effects
- 0.3 mg/kg IV (preferred) or SC (max 20mg)
- Onset of action ~1hr, duration of action ~4-24hr
- Cryoprecipitate
- May be used to replace fibrinogen in patients with fibrinogen levels <100
- 1 bag per 10kg of body weight
- Platlets
- Aim for >50K for moderate risk procedures; >100K for high risk procedures
- FFP
- Use with caution; requires large volume of FFP to make a significant difference
- PPI/pepcid/octreotide (variceal bleed)